Both in Pharmaceuticals
Kailera Therapeutics vs Nuvation Bio
Over the past year KLRA returned −9.8% and NUVB returned −22.7%; their daily moves had a correlation of 0.33.
KLRA −9.8% NUVB −22.7%Growth of $1, one year, split-adjusted
| Metric | KLRA | NUVB |
|---|---|---|
| Price | $12.58 | $4.69 |
| Market cap | $1.63B | $1.65B |
| Today | +3.54% | +2.18% |
| 1 month | +16.1% | −5.3% |
| 6 months | — | −2.9% |
| Year to date | — | −47.7% |
| 1 year | — | −10.2% |
| Revenue growth (YoY) | — | +555.6% |
| Gross margin | — | 73.0% |
| Net margin | — | −198.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.7× |
| Net cash | $916.7M | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 51.1% |
| Short % of float | 9.1% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).